Breast Cancer Research and Treatment

, Volume 144, Issue 3, pp 479–502 | Cite as

Mammographic density—a review on the current understanding of its association with breast cancer

  • C. W. HuoEmail author
  • G. L. Chew
  • K. L. Britt
  • W. V. Ingman
  • M. A. Henderson
  • J. L. Hopper
  • E. W. Thompson


There has been considerable recent interest in the genetic, biological and epidemiological basis of mammographic density (MD), and the search for causative links between MD and breast cancer (BC) risk. This report will critically review the current literature on MD and summarize the current evidence for its association with BC. Keywords ‘mammographic dens*’, ‘dense mammary tissue’ or ‘percent dens*’ were used to search the existing literature in English on PubMed and Medline. All reports were critically analyzed. The data were assigned to one of the following aspects of MD: general association with BC, its relationship with the breast hormonal milieu, the cellular basis of MD, the generic variations of MD, and its significance in the clinical setting. MD adjusted for age, and BMI is associated with increased risk of BC diagnosis, advanced tumour stage at diagnosis and increased risk of both local recurrence and second primary cancers. The MD measures that predict BC risk have high heritability, and to date several genetic markers associated with BC risk have been found to also be associated with these MD risk predictors. Change in MD could be a predictor of the extent of chemoprevention with tamoxifen. Although the biological and genetic pathways that determine and perhaps modulate MD remain largely unresolved, significant inroads are being made into the understanding of MD, which may lead to benefits in clinical screening, assessment and treatment strategies. This review provides a timely update on the current understanding of MD’s association with BC risk.


Mammographic density Breast cancer risk Stroma Adipose tissue Tamoxifen Biochamber Extracellular matrix Breast cancer screening 


Conflict of interest

The authors declare that they have no conflict of interests.


  1. 1.
    Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236. doi: 10.1056/NEJMoa062790 PubMedGoogle Scholar
  2. 2.
    McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169. doi: 10.1158/1055-9965.EPI-06-0034 PubMedGoogle Scholar
  3. 3.
    Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37(5):2486–2492PubMedGoogle Scholar
  4. 4.
    Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148(6):1087–1092. doi: 10.2214/ajr.148.6.1087 PubMedGoogle Scholar
  5. 5.
    American College of Radiology (2004) Breast Imaging Reporting and Data System. 4th ed. American College of Radiology, RestonGoogle Scholar
  6. 6.
    He W, Denton ERE, Stafford K, Zwiggelaar R (2011) Mammographic image segmentation and risk classification based on mammographic parenchymal patterns and geometric moments. Biomed Signal Process Control 6(3):321–329Google Scholar
  7. 7.
    Woolcott CG, Conroy SM, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano IS, Byrne C, Maskarinec G (2014) Methods for assessing and representing mammographic density: an analysis of 4 case-control studies. Am J Epidemiol 179(2):236–244. doi: 10.1093/aje/kwt238 PubMedGoogle Scholar
  8. 8.
    Baglietto L, Krishnan K, Stone J, Apicella C, Southey M, English DR, Hopper J, Giles GG (2013) Associations of mammographic dense, non-dense area and body mass index with risk of breast cancer. Am J Epidemiol 179(4):475–483Google Scholar
  9. 9.
    Nguyen TL, Schmidt DF, Makalic E, Dite GS, Stone J, Apicella C, Bui M, MacInnis RJ, Odefrey F, Cawson J, Treloar S, Southey M, Giles GG, Hopper J (2013) Cumulus mammographic measures that predict breast cancer risk: a twins and sisters study. Cancer Epidemiol Biomarkers Prev 22(12):2395–2403Google Scholar
  10. 10.
    Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(11):2086–2092. doi: 10.1158/1055-9965.EPI-06-0345 PubMedGoogle Scholar
  11. 11.
    Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH (2005) Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2634–2640. doi: 10.1158/1055-9965.EPI-05-0824 PubMedGoogle Scholar
  12. 12.
    Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Sternfeld B, Cauley JA (2009) Longitudinal association of anthropometry with mammographic breast density in the Study of Women’s Health Across the Nation. Int J Cancer 124(5):1169–1177. doi: 10.1002/ijc.23996 PubMedCentralPubMedGoogle Scholar
  13. 13.
    Heng D, Gao F, Jong R, Fishell E, Yaffe M, Martin L, Li T, Stone J, Sun L, Hopper J, Boyd NF (2004) Risk factors for breast cancer associated with mammographic features in Singaporean Chinese women. Cancer Epidemiol Biomarkers Prev 13(11 Pt 1):1751–1758PubMedGoogle Scholar
  14. 14.
    Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14(2):243–250. doi: 10.1097/01.gme.0000235362.72899.7b PubMedGoogle Scholar
  15. 15.
    Maskarinec G, Nagata C, Shimizu H, Kashiki Y (2002) Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 102(1):29–33. doi: 10.1002/ijc.10673 PubMedGoogle Scholar
  16. 16.
    Tamimi RM, Hankinson SE, Colditz GA, Byrne C (2005) Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2641–2647. doi: 10.1158/1055-9965.EPI-05-0558 PubMedGoogle Scholar
  17. 17.
    Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL (1998) The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer 78(9):1233–1238PubMedCentralPubMedGoogle Scholar
  18. 18.
    Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M, Quesenberry C, Sternfeld B (2007) Mammographic density in a multiethnic cohort. Menopause 14(5):891–899. doi: 10.1097/gme.0b013e318032569c PubMedGoogle Scholar
  19. 19.
    Liao DJ, Dickson RB (2002) Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80(2):175–189PubMedGoogle Scholar
  20. 20.
    Liu ZJ, Zhuge Y, Velazquez OC (2009) Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106(6):984–991. doi: 10.1002/jcb.22091 PubMedGoogle Scholar
  21. 21.
    Nakatani H, Aoki N, Okajima T, Nadano D, Flint D, Matsuda T (2010) Establishment of a mammary stromal fibroblastic cell line for in vitro studies in mice of mammary adipocyte differentiation. Biol Reprod 82(1):44–53. doi: 10.1095/biolreprod.109.077958 PubMedGoogle Scholar
  22. 22.
    Aiello EJ, Buist DS, White E, Porter PL (2005) Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 14(3):662–668. doi: 10.1158/1055-9965 PubMedGoogle Scholar
  23. 23.
    Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103(15):1179–1189. doi: 10.1093/jnci/djr225 PubMedCentralPubMedGoogle Scholar
  24. 24.
    Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28(24):3830–3837. doi: 10.1200/JCO.2009.26.4770 PubMedCentralPubMedGoogle Scholar
  25. 25.
    Maskarinec G, Pagano IS, Little MA, Conroy SM, Park SY, Kolonel LN (2013) Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort. Breast Cancer Res 15(1):R7. doi: 10.1186/bcr3378 PubMedCentralPubMedGoogle Scholar
  26. 26.
    Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012) Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 104(16):1218–1227. doi: 10.1093/jnci/djs327 PubMedCentralPubMedGoogle Scholar
  27. 27.
    Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA, McCready DR (2009) Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 115(24):5780–5787. doi: 10.1002/cncr.24638 PubMedGoogle Scholar
  28. 28.
    Buist DS, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, Carney PA, Kerlikowske K, Geller BM (2010) Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 124(3):863–873. doi: 10.1007/s10549-010-1106-6 PubMedCentralPubMedGoogle Scholar
  29. 29.
    Habel LA, Capra AM, Achacoso NS, Janga A, Acton L, Puligandla B, Quesenberry CP Jr (2010) Mammographic density and risk of second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 19(10):2488–2495. doi: 10.1158/1055-9965.EPI-10-0769 PubMedGoogle Scholar
  30. 30.
    Hwang ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K (2007) Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev 16(12):2587–2593. doi: 10.1158/1055-9965.EPI-07-0458 PubMedGoogle Scholar
  31. 31.
    Couto E, Qureshi SA, Hofvind S, Hilsen M, Aase H, Skaane P, Vatten L, Ursin G (2012) Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 132(1):297–305. doi: 10.1007/s10549-011-1810-x PubMedGoogle Scholar
  32. 32.
    Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95(1):30–37PubMedGoogle Scholar
  33. 33.
    Persson I, Thurfjell E, Holmberg L (1997) Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 15(10):3201–3207PubMedGoogle Scholar
  34. 34.
    van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25(11):1323–1328. doi: 10.1200/JCO.2005.04.7332 PubMedGoogle Scholar
  35. 35.
    Boyd NF, Martin LJ, Li Q, Sun L, Chiarelli AM, Hislop G, Yaffe MJ, Minkin S (2006) Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):961–966. doi: 10.1158/1055-9965.EPI-05-0762 PubMedGoogle Scholar
  36. 36.
    Aiello EJ, Buist DS, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States). Cancer Causes Control 17(10):1227–1235. doi: 10.1007/s10552-006-0073-z PubMedGoogle Scholar
  37. 37.
    Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006) Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118(7):1782–1789. doi: 10.1002/ijc.21558 PubMedGoogle Scholar
  38. 38.
    Barcus CE, Keely PJ, Eliceiri KW, Schuler LA (2013) Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. J Biol Chem 288(18):12722–12732. doi: 10.1074/jbc.M112.447631 PubMedGoogle Scholar
  39. 39.
    Chew GL, Huang D, Huo CW, Blick T, Hill P, Cawson J, Frazer H, Southey MC, Hopper J, Henderson M, Haviv I, Thompson EW (2013) Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time. Breast Cancer Res Treat 140(2):285–297Google Scholar
  40. 40.
    Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2006) Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 12(4):186–193. doi: 10.1258/136218006779160436 PubMedGoogle Scholar
  41. 41.
    Bentzon N, During M, Rasmussen BB, Mouridsen H, Kroman N (2008) Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 122(5):1089–1094. doi: 10.1002/ijc.22892 PubMedGoogle Scholar
  42. 42.
    Antoni S, Sasco AJ, dos Santos Silva I, McCormack V (2013) Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat 137 (2):337–347. doi: 10.1007/s10549-012-2362-4 Google Scholar
  43. 43.
    Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales-Martinez JE, Pastor-Barriuso R (2013) Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case–control study. Breast Cancer Res 15(1):R9. doi: 10.1186/bcr3380 PubMedCentralPubMedGoogle Scholar
  44. 44.
    Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87(8):876–882. doi: 10.1038/sj.bjc.6600537 PubMedCentralPubMedGoogle Scholar
  45. 45.
    Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798–808. doi: 10.1016/S1470-2045(05)70390-9 PubMedGoogle Scholar
  46. 46.
    James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schutze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodriguez L, Buckland G, Sanchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham N, Key TJ, Allen NE, Romieu I, Siddiq A, Cox D, Riboli E, Kaaks R (2011) Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case–control study. Cancer Prev Res (Phila) 4(10):1626–1635. doi: 10.1158/1940-6207.CAPR-11-00901940-6207.CAPR-11-0090 Google Scholar
  47. 47.
    Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303(5920):767–770PubMedGoogle Scholar
  48. 48.
    Heusinger K, Jud SM, Haberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA (2012) Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer 131(11):2643–2649. doi: 10.1002/ijc.27515 PubMedGoogle Scholar
  49. 49.
    Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, Widschwendter M, Schett G, Penninger JM (2010) Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468(7320):98–102. doi: 10.1038/nature09387 PubMedCentralPubMedGoogle Scholar
  50. 50.
    Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R (2010) Progesterone induces adult mammary stem cell expansion. Nature 465(7299):803–807. doi: 10.1038/nature09091 PubMedGoogle Scholar
  51. 51.
    Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz VS, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM (2013) Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15(6):R104. doi: 10.1186/bcr3570 PubMedPubMedCentralGoogle Scholar
  52. 52.
    Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM (2012) Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat 131(1):267–275. doi: 10.1007/s10549-011-1727-4 PubMedCentralPubMedGoogle Scholar
  53. 53.
    Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW (2011) Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat 128(2):505–516. doi: 10.1007/s10549-011-1346-0 PubMedGoogle Scholar
  54. 54.
    Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH (2003) Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5(5):R129–R135. doi: 10.1186/bcr622 PubMedCentralPubMedGoogle Scholar
  55. 55.
    Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC (1995) Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 142(8):813–819PubMedGoogle Scholar
  56. 56.
    Fisher ER, Palekar A, Kim WS, Redmond C (1978) The histopathology of mammographic patterns. Am J Clin Pathol 69(4):421–426PubMedGoogle Scholar
  57. 57.
    Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000) Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study. Eur J Cancer Prev 9(1):15–24PubMedGoogle Scholar
  58. 58.
    Heusinger K, Jud SM, Haberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL (2012) Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 135(3):885–892. doi: 10.1007/s10549-012-2221-3 PubMedGoogle Scholar
  59. 59.
    Verheus M, Maskarinec G, Erber E, Steude JS, Killeen J, Hernandez BY, Cline JM (2009) Mammographic density and epithelial histopathologic markers. BMC Cancer 9:182. doi: 10.1186/1471-2407-9-182 PubMedCentralPubMedGoogle Scholar
  60. 60.
    Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J (2008) Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 15(1):67–73. doi: 10.1097/gme.0b013e318054e29a PubMedGoogle Scholar
  61. 61.
    Rice MS, Tworoger SS, Rosner BA, Pollak MN, Hankinson SE, Tamimi RM (2012) Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies. Breast Cancer Res Treat 136(3):805–812. doi: 10.1007/s10549-012-2303-2 PubMedCentralPubMedGoogle Scholar
  62. 62.
    DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, Marx JJ, Tjoe JA, Ziv E, Febbraio M, Kerlikowske K, Parvin B, Tlsty TD (2012) CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2(9):826–839. doi: 10.1158/2159-8290.CD-12-0107 Google Scholar
  63. 63.
    Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med 6:11. doi: 10.1186/1741-7015-6-11 PubMedCentralPubMedGoogle Scholar
  64. 64.
    Keely PJ (2011) Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 16(3):205–219. doi: 10.1007/s10911-011-9226-0 PubMedGoogle Scholar
  65. 65.
    Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW (2006) Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 235(12):3222–3229. doi: 10.1002/dvdy.20972 PubMedGoogle Scholar
  66. 66.
    Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10(3):243–248PubMedGoogle Scholar
  67. 67.
    Provenzano PP, Inman DR, Eliceiri KW, Keely PJ (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28(49):4326–4343. doi: 10.1038/onc.2009.299 PubMedCentralPubMedGoogle Scholar
  68. 68.
    Raviraj V, Fok S, Zhao J, Chien HY, Lyons JG, Thompson EW, Soon L (2012) Regulation of ROCK1 via Notch1 during breast cancer cell migration into dense matrices. BMC Cell Biol 13:12. doi: 10.1186/1471-2121-13-12 PubMedCentralPubMedGoogle Scholar
  69. 69.
    Raviraj V, Zhang H, Chien HY, Cole L, Thompson EW, Soon L (2012) Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clin Exp Metastasis 29(3):273–292. doi: 10.1007/s10585-011-9450-4 PubMedGoogle Scholar
  70. 70.
    Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65(12):5278–5283. doi: 10.1158/0008-5472.CAN-04-1853 PubMedGoogle Scholar
  71. 71.
    Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727–740PubMedCentralPubMedGoogle Scholar
  72. 72.
    Hariri M, Wood GA, DiGrappa MA, MacPherson M, Backman SA, Yaffe MJ, Mak TW, Boyd NF, Khokha R (2004) Experimental manipulation of radiographic density in mouse mammary gland. Breast Cancer Res 6(5):R540–R545. doi: 10.1186/bcr901 PubMedCentralPubMedGoogle Scholar
  73. 73.
    Chew GL, Huang D, Lin SJ, Huo C, Blick T, Henderson MA, Hill P, Cawson J, Morrison WA, Campbell IG, Hopper JL, Southey MC, Haviv I, Thompson EW (2012) High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers. Breast Cancer Res Treat 135(1):177–187. doi: 10.1007/s10549-012-2128-z PubMedGoogle Scholar
  74. 74.
    Kaprio J, Alanko A, Kivisaari L, Standertskjold-Nordenstam CG (1987) Mammographic patterns in twin pairs discordant for breast cancer. Brit J Radiol 60(713):459–462PubMedGoogle Scholar
  75. 75.
    Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA (1997) Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst 89(8):549–556PubMedGoogle Scholar
  76. 76.
    Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886–894. doi: 10.1056/NEJMoa013390 Google Scholar
  77. 77.
    Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL (2006) The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev 15(4):612–617. doi: 10.1158/1055-9965.EPI-05-0127 PubMedGoogle Scholar
  78. 78.
    Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093. doi: 10.1038/nature05887 PubMedCentralPubMedGoogle Scholar
  79. 79.
    Martin LJ, Melnichouk O, Guo H, Chiarelli AM, Hislop TG, Yaffe MJ, Minkin S, Hopper JL, Boyd NF (2010) Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 19(2):456–463. doi: 10.1158/1055-9965.EPI-09-0881 PubMedGoogle Scholar
  80. 80.
    Odefrey F, Stone J, Gurrin LC, Byrnes GB, Apicella C, Dite GS, Cawson JN, Giles GG, Treloar SA, English DR, Hopper JL, Southey MC (2010) Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res 70(4):1449–1458. doi: 10.1158/0008-5472.CAN-09-3495 PubMedGoogle Scholar
  81. 81.
    Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim G, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N, McCormack VA, Biong M, Alnaes GI, Gram IT, Kristensen VN, Borresen-Dale AL, Lindstrom S, Hankinson SE, Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figuero JD, Lissowska J, Wesolowska E, Peplonska B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper JL, dos-Santos-Silva I (2012) Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 21(7):1156–1166. doi: 10.1158/1055-9965.EPI-12-0066 Google Scholar
  82. 82.
    Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, Brown J, Leyland J, Audley T, Wareham NJ, Loos RJ, Paterson AD, Rommens J, Waggott D, Martin LJ, Scott CG, Pankratz VS, Hankinson SE, Hazra A, Hunter DJ, Hopper JL, Southey MC, Chanock SJ, Silva Idos S, Liu J, Eriksson L, Couch FJ, Stone J, Apicella C, Czene K, Kraft P, Hall P, Easton DF, Boyd NF, Tamimi RM (2011) Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet 43(3):185–187. doi: 10.1038/ng.760 PubMedCentralPubMedGoogle Scholar
  83. 83.
    Stevens KN, Lindstrom S, Scott CG, Thompson D, Sellers TA, Wang X, Wang A, Atkinson E, Rider DN, Eckel-Passow JE, Varghese JS, Audley T, Brown J, Leyland J, Luben RN, Warren RM, Loos RJ, Wareham NJ, Li J, Hall P, Liu J, Eriksson L, Czene K, Olson JE, Pankratz VS, Fredericksen Z, Diasio RB, Lee AM, Heit JA, DeAndrade M, Goode EL, Vierkant RA, Cunningham JM, Armasu SM, Weinshilboum R, Fridley BL, Batzler A, Ingle JN, Boyd NF, Paterson AD, Rommens J, Martin LJ, Hopper JL, Southey MC, Stone J, Apicella C, Kraft P, Hankinson SE, Hazra A, Hunter DJ, Easton DF, Couch FJ, Tamimi RM, Vachon CM (2012) Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet 21(14):3299–3305. doi: 10.1093/hmg/dds158 PubMedCentralPubMedGoogle Scholar
  84. 84.
    Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA (2013) Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 19(18):4972–4982. doi: 10.1158/1078-0432.CCR-13-0029 PubMedGoogle Scholar
  85. 85.
    Pawluczyk O, Augustine BJ, Yaffe MJ, Rico D, Yang J, Mawdsley GE, Boyd NF (2003) A volumetric method for estimation of breast density on digitized screen-film mammograms. Med Phys 30(3):352–364PubMedGoogle Scholar
  86. 86.
    Shepherd JA, Kerlikowske K, Ma L, Duewer F, Fan B, Wang J, Malkov S, Vittinghoff E, Cummings SR (2011) Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 20(7):1473–1482. doi: 10.1158/1055-9965.EPI-10-1150 PubMedCentralPubMedGoogle Scholar
  87. 87.
    Heine JJ, Scott CG, Sellers TA, Brandt KR, Serie DJ, Wu FF, Morton MJ, Schueler BA, Couch FJ, Olson JE, Pankratz VS, Vachon CM (2012) A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst 104(13):1028–1037. doi: 10.1093/jnci/djs254 PubMedCentralPubMedGoogle Scholar
  88. 88.
    Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629–1638PubMedGoogle Scholar
  89. 89.
    Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13(6):223. doi: 10.1186/bcr2942 PubMedCentralPubMedGoogle Scholar
  90. 90.
    Nickson C, Arzhaeva Y, Aitken Z, Elgindy T, Buckley M, Li M, English DR, Kavanagh AM (2013) AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes. Breast Cancer Res 15(5):R80. doi: 10.1186/bcr3474 PubMedPubMedCentralGoogle Scholar
  91. 91.
    Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103(9):744–752. doi: 10.1093/jnci/djr079 PubMedGoogle Scholar
  92. 92.
    Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P (2013) Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31(18):2249–2256. doi: 10.1200/JCO.2012.44.5015 PubMedGoogle Scholar
  93. 93.
    Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Han SW, Im SA, Kim TY, Koo HR, Chang JM, Cho N, Moon WK, Noh DY (2012) Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res 14(4):R102. doi: 10.1186/bcr3221 PubMedCentralPubMedGoogle Scholar
  94. 94.
    Grady D (2012) New laws add a divisive component to breast screening. The New York Times. Accessed 23 July 2013
  95. 95.
    AreYouDense (2013) Are you dense? Exposing the best-kept secret™.
  96. 96.
    Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE (2012) Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 265(1):59–69. doi: 10.1148/radiol.12120621 PubMedGoogle Scholar
  97. 97.
    Weigert J, Steenbergen S (2012) The connecticut experiment: the role of ultrasound in the screening of women with dense breasts. Breast J 18(6):517–522. doi: 10.1111/tbj.12003 PubMedGoogle Scholar
  98. 98.
    Moon WK, Shen YW, Huang CS, Luo SC, Kuzucan A, Chen JH, Chang RF (2011) Comparative study of density analysis using automated whole breast ultrasound and MRI. Med Phys 38(1):382–389PubMedCentralPubMedGoogle Scholar
  99. 99.
    Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, Bohm-Velez M, Mahoney MC, Evans WP 3rd, Larsen LH, Morton MJ, Mendelson EB, Farria DM, Cormack JB, Marques HS, Adams A, Yeh NM, Gabrielli G (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307(13):1394–1404. doi: 10.1001/jama.2012.388 PubMedCentralPubMedGoogle Scholar
  100. 100.
    Tagliafico A, Tagliafico G, Astengo D, Cavagnetto F, Rosasco R, Rescinito G, Monetti F, Calabrese M (2012) Mammographic density estimation: one-to-one comparison of digital mammography and digital breast tomosynthesis using fully automated software. Eur Radiol 22(6):1265–1270. doi: 10.1007/s00330-012-2380-y PubMedGoogle Scholar
  101. 101.
    Linton L, Martin LJ, Li Q, Huszti E, Minkin S, John EM, Rommens J, Paterson AD, Boyd NF (2013) Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry. Breast Cancer Res 15(3):R43. doi: 10.1186/bcr3430 PubMedCentralPubMedGoogle Scholar
  102. 102.
    Tice JA, O’Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105(14):1043–1049. doi: 10.1093/jnci/djt124 PubMedGoogle Scholar
  103. 103.
    Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2013) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomarkers Prev 22(6):1110–1117. doi: 10.1158/1055-9965.EPI-13-0169 PubMedGoogle Scholar
  104. 104.
    Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, Weissfeld JL, Wolmark N (2012) Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). Cancer Prev Res (Phila) 5(11):1321–1329. doi: 10.1158/1940-6207.CAPR-12-0273 Google Scholar
  105. 105.
    Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC (2012) Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat 135(2):571–580. doi: 10.1007/s10549-012-2185-3 PubMedCentralPubMedGoogle Scholar
  106. 106.
    Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH (2011) Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13(5):R103. doi: 10.1186/bcr3044 PubMedCentralPubMedGoogle Scholar
  107. 107.
    Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13(5):R100. doi: 10.1186/bcr3041 PubMedCentralPubMedGoogle Scholar
  108. 108.
    Stone J, Ding J, Warren RM, Duffy SW, Hopper JL (2010) Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 12(6):R97. doi: 10.1186/bcr2778 PubMedCentralPubMedGoogle Scholar
  109. 109.
    Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH (2010) Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19(5):1219–1228. doi: 10.1158/1055-9965.EPI-09-1028 PubMedGoogle Scholar
  110. 110.
    Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E (2009) Breast density and outcome of mammography screening: a cohort study. Br J Cancer 100(7):1205–1208. doi: 10.1038/sj.bjc.6604989 PubMedCentralPubMedGoogle Scholar
  111. 111.
    Kavanagh AM, Byrnes GB, Nickson C, Cawson JN, Giles GG, Hopper JL, Gertig DM, English DR (2008) Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev 17(10):2818–2824. doi: 10.1158/1055-9965.EPI-07-2835 PubMedGoogle Scholar
  112. 112.
    Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99(15):1178–1187. doi: 10.1093/jnci/djm062 PubMedGoogle Scholar
  113. 113.
    Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA (2007) Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(1):43–49. doi: 10.1158/1055-9965.EPI-06-0738 PubMedGoogle Scholar
  114. 114.
    Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P (2013) Possible influence of mammographic density on local and locoregional recurrence of breast cancer. Breast Cancer Res 15(4):R56. doi: 10.1186/bcr3450 PubMedPubMedCentralGoogle Scholar
  115. 115.
    Sandberg ME, Li J, Hall P, Hartman M, Dos-Santos-Silva I, Humphreys K, Czene K (2013) Change of mammographic density predicts the risk of contralateral breast cancer—a case–control study. Breast Cancer Res 15(4):R57. doi: 10.1186/bcr3451 PubMedPubMedCentralGoogle Scholar
  116. 116.
    Lowry SJ, Aiello Bowles EJ, Anderson ML, Buist DS (2011) Predictors of breast density change after hormone therapy cessation: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 20(10):2309–2312. doi: 10.1158/1055-9965.EPI-11-0629 PubMedCentralPubMedGoogle Scholar
  117. 117.
    Chen FP, Cheung YC, Soong YK (2010) Factors that influence changes in mammographic density with postmenopausal hormone therapy. Taiwan J Obstet Gynecol 49(4):413–418. doi: 10.1016/S1028-4559(10)60091-5 PubMedGoogle Scholar
  118. 118.
    Nielsen M, Pettersen PC, Alexandersen P, Karemore G, Raundahl J, Loog M, Christiansen C (2010) Breast density changes associated with postmenopausal hormone therapy: post hoc radiologist- and computer-based analyses. Menopause 17(4):772–778. doi: 10.1097/gme.0b013e3181cd4172 PubMedGoogle Scholar
  119. 119.
    Stuedal A, Ma H, Bjorndal H, Ursin G (2009) Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric 12(3):248–258. doi: 10.1080/13697130802638458 PubMedGoogle Scholar
  120. 120.
    Bremnes Y, Ursin G, Bjurstam N, Lund E, Gram IT (2007) Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Int J Cancer 120(4):880–884. doi: 10.1002/ijc.22437 PubMedGoogle Scholar
  121. 121.
    Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P (2012) The influence of mammographic density on breast tumor characteristics. Breast Cancer Res Treat 134(2):859–866. doi: 10.1007/s10549-012-2127-0 PubMedGoogle Scholar
  122. 122.
    Eriksson L, Hall P, Czene K, Dos Santos Silva I, McCormack V, Bergh J, Bjohle J, Ploner A (2012) Mammographic density and molecular subtypes of breast cancer. Br J Cancer 107(1):18–23. doi: 10.1038/bjc.2012.234 PubMedCentralPubMedGoogle Scholar
  123. 123.
    Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O’Meara ES, Li CI (2012) Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 22(5):340–348. doi: 10.1016/j.annepidem.2012.02.002 PubMedCentralPubMedGoogle Scholar
  124. 124.
    Conroy SM, Pagano I, Kolonel LN, Maskarinec G (2011) Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol 35(5):448–452. doi: 10.1016/j.canep.2010.11.011 PubMedCentralPubMedGoogle Scholar
  125. 125.
    Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M (2010) Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 17(Suppl 3):211–218. doi: 10.1245/s10434-010-1237-3 PubMedGoogle Scholar
  126. 126.
    Passaperuma K, Warner E, Hill KA, Gunasekara A, Yaffe MJ (2010) Is mammographic breast density a breast cancer risk factor in women with BRCA mutations? J Clin Oncol 28(23):3779–3783. doi: 10.1200/JCO.2009.27.5933 PubMedGoogle Scholar
  127. 127.
    Ding J, Warren R, Girling A, Thompson D, Easton D (2010) Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 16(3):279–289. doi: 10.1111/j.1524-4741.2010.00907.x PubMedGoogle Scholar
  128. 128.
    Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH (2010) Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 123(1):245–255. doi: 10.1007/s10549-010-0749-7 PubMedCentralPubMedGoogle Scholar
  129. 129.
    Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G (2009) Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 18(2):479–485. doi: 10.1158/1055-9965.EPI-08-0805 PubMedGoogle Scholar
  130. 130.
    Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Vachon CM (2008) Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(4):872–879. doi: 10.1158/1055-9965.EPI-07-0559 PubMedCentralPubMedGoogle Scholar
  131. 131.
    Pollan M, Llobet R, Miranda-Garcia J, Anton J, Casals M, Martinez I, Palop C, Ruiz-Perales F, Sanchez-Contador C, Vidal C, Perez-Gomez B, Salas-Trejo D (2013) Validation of DM-Scan, a computer-assisted tool to assess mammographic density in full-field digital mammograms. SpringerPlus 2(1):242. doi: 10.1186/2193-1801-2-242 PubMedCentralPubMedGoogle Scholar
  132. 132.
    Seo JM, Ko ES, Han BK, Ko EY, Shin JH, Hahn SY (2013) Automated volumetric breast density estimation: a comparison with visual assessment. Clin Radiol 68(7):690–695. doi: 10.1016/j.crad.2013.01.011 PubMedGoogle Scholar
  133. 133.
    Li J, Szekely L, Eriksson L, Heddson B, Sundbom A, Czene K, Hall P, Humphreys K (2012) High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer. Breast Cancer Res 14(4):R114. doi: 10.1186/bcr3238 PubMedCentralPubMedGoogle Scholar
  134. 134.
    Spayne MC, Gard CC, Skelly J, Miglioretti DL, Vacek PM, Geller BM (2012) Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study. Breast J 18(4):326–333. doi: 10.1111/j.1524-4741.2012.01250.x PubMedCentralPubMedGoogle Scholar
  135. 135.
    Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, Kaaks R, Chang-Claude J (2012) Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int J Cancer 130(6):1401–1410. doi: 10.1002/ijc.26157 PubMedGoogle Scholar
  136. 136.
    Corsetti V, Houssami N, Ghirardi M, Ferrari A, Speziani M, Bellarosa S, Remida G, Gasparotti C, Galligioni E, Ciatto S (2011) Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. Eur J Cancer 47(7):1021–1026. doi: 10.1016/j.ejca.2010.12.002 PubMedGoogle Scholar
  137. 137.
    Thompson DJ, Leach MO, Kwan-Lim G, Gayther SA, Ramus SJ, Warsi I, Lennard F, Khazen M, Bryant E, Reed S, Boggis CR, Evans DG, Eeles RA, Easton DF, Warren RM (2009) Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study. Breast Cancer Res 11(6):R80. doi: 10.1186/bcr2447 PubMedCentralPubMedGoogle Scholar
  138. 138.
    Nickson C, Kavanagh AM (2009) Tumour size at detection according to different measures of mammographic breast density. J Med Screen 16(3):140–146. doi: 10.1258/jms.2009.009054 PubMedGoogle Scholar
  139. 139.
    Boyd N, Martin L, Gunasekara A, Melnichouk O, Maudsley G, Peressotti C, Yaffe M, Minkin S (2009) Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev 18(6):1754–1762. doi: 10.1158/1055-9965.EPI-09-0107 PubMedGoogle Scholar
  140. 140.
    Tagliafico A, Tagliafico G, Tosto S, Chiesa F, Martinoli C, Derchi LE, Calabrese M (2009) Mammographic density estimation: comparison among BI-RADS categories, a semi-automated software and a fully automated one. Breast 18(1):35–40. doi: 10.1016/j.breast.2008.09.005 PubMedGoogle Scholar
  141. 141.
    Heine JJ, Carston MJ, Scott CG, Brandt KR, Wu FF, Pankratz VS, Sellers TA, Vachon CM (2008) An automated approach for estimation of breast density. Cancer Epidemiol Biomarkers Prev 17(11):3090–3097. doi: 10.1158/1055-9965.EPI-08-0170 PubMedCentralPubMedGoogle Scholar
  142. 142.
    Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, D’Orsi CJ, Jong RA, Rebner M, Tosteson AN, Gatsonis CA (2008) Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246(2):376–383. doi: 10.1148/radiol.2461070200 PubMedCentralPubMedGoogle Scholar
  143. 143.
    McCormack VA, Highnam R, Perry N, dos Santos Silva I (2007) Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Prev 16(6):1148–1154. doi: 10.1158/1055-9965.EPI-07-0085 Google Scholar
  144. 144.
    Li J, Czene K, Brauch H, Schroth W, Saladores P, Li Y, Humphreys K, Hall P (2013) Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment. Breast Cancer Res 15(5):R93. doi: 10.1186/bcr3495 PubMedPubMedCentralGoogle Scholar
  145. 145.
    Henry NL, Chan HP, Dantzer J, Goswami CP, Li L, Skaar TC, Rae JM, Desta Z, Khouri N, Pinsky R, Oesterreich S, Zhou C, Hadjiiski L, Philips S, Robarge J, Nguyen AT, Storniolo AM, Flockhart DA, Hayes DF, Helvie MA, Stearns V (2013) Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects. Br J Cancer 109(9):2331–2339. doi: 10.1038/bjc.2013.587 PubMedGoogle Scholar
  146. 146.
    Vachon CM, Suman VJ, Brandt KR, Kosel ML, Buzdar AU, Olson JE, Wu FF, Flickinger LM, Ursin G, Elliott CR, Shepherd L, Weinshilboum RM, Goss PE, Ingle JN (2013) Mammographic breast density response to aromatase inhibition. Clin Cancer Res 19(8):2144–2153. doi: 10.1158/1078-0432.CCR-12-2789 PubMedPubMedCentralGoogle Scholar
  147. 147.
    Prowell TM, Blackford AL, Byrne C, Khouri NF, Dowsett M, Folkerd E, Tarpinian KS, Powers PP, Wright LA, Donehower MG, Jeter SC, Armstrong DK, Emens LA, Fetting JH, Wolff AC, Garrett-Mayer E, Skaar TC, Davidson NE, Stearns V (2011) Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole. Cancer Prev Res (Phila) 4(12):1993–2001. doi: 10.1158/1940-6207.CAPR-11-0154 Google Scholar
  148. 148.
    Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE (2010) A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat 120(2):427–435. doi: 10.1007/s10549-009-0662-0 PubMedGoogle Scholar
  149. 149.
    Mousa NA, Crystal P, Wolfman WL, Bedaiwy MA, Casper RF (2008) Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause 15(5):875–884. doi: 10.1097/gme.0b013e31816956c3 PubMedGoogle Scholar
  150. 150.
    Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008) Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG 115(6):773–779. doi: 10.1111/j.1471-0528.2008.01690.x PubMedGoogle Scholar
  151. 151.
    Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, Gibson L, Hillier SG, Holly JM, Moss S, Dowsett M, Peto J, dos Santos Silva I (2009) Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 69(16):6490–6499. doi: 10.1158/0008-5472.CAN-09-0280 Google Scholar
  152. 152.
    McCormack VA, Dowsett M, Folkerd E, Johnson N, Palles C, Coupland B, Holly JM, Vinnicombe SJ, Perry NM, dos Santos Silva I (2009) Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res 11(3):R38. doi: 10.1186/bcr2325 Google Scholar
  153. 153.
    Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A (2008) Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 108(1):57–67. doi: 10.1007/s10549-007-9577-9 PubMedGoogle Scholar
  154. 154.
    Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT (2007) Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 121(11):2506–2511. doi: 10.1002/ijc.22971 PubMedGoogle Scholar
  155. 155.
    Khan QJ, Kimler BF, O’Dea AP, Zalles CM, Sharma P, Fabian CJ (2007) Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res 9(3):R35. doi: 10.1186/bcr1683 PubMedCentralPubMedGoogle Scholar
  156. 156.
    Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I, Hayashi K, Arendell L, Skeie G, Rinaldi S, Kaaks R (2007) IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 121(8):1786–1792. doi: 10.1002/ijc.22834 PubMedGoogle Scholar
  157. 157.
    Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 16(3):451–457. doi: 10.1158/1055-9965.EPI-06-0642 PubMedGoogle Scholar
  158. 158.
    Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT (2007) Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev 16(1):57–62. doi: 10.1158/1055-9965.EPI-06-0788 PubMedGoogle Scholar
  159. 159.
    Ozhand A, Lee E, Wu AH, Ellingjord-Dale M, Akslen LA, McKean-Cowdin R, Ursin G (2013) Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PLoS ONE 8(6):e65313. doi: 10.1371/journal.pone.0065313 PubMedCentralPubMedGoogle Scholar
  160. 160.
    Lee E, Su YC, Lewinger JP, Hsu C, Van Den Berg D, Ursin G, Koh WP, Yuan JM, Stram DO, Yu MC, Wu AH (2013) Hormone metabolism genes and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 22(5):984–986. doi: 10.1158/1055-9965.EPI-13-0157 PubMedGoogle Scholar
  161. 161.
    Lee E, Van Den Berg D, Hsu C, Ursin G, Koh WP, Yuan JM, Stram DO, Yu MC, Wu AH (2013) Genetic variation in transforming growth factor beta 1 and mammographic density in Singapore Chinese women. Cancer Res 73(6):1876–1882. doi: 10.1158/0008-5472.CAN-12-1870 PubMedCentralPubMedGoogle Scholar
  162. 162.
    de Aguiar ES, Giacomazzi J, Schmidt AV, Bock H, Saraiva-Pereira ML, Schuler-Faccini L, Duarte Filho D, dos Santos PA, Giugliani R, Caleffi M, Camey SA, Ashton-Prolla P (2012) GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening. Rev Bras Epidemiol 15(2):246–255. doi: 10.1590/S1415-790X2012000200002 PubMedGoogle Scholar
  163. 163.
    Stone J, Dite GS, Giles GG, Cawson J, English DR, Hopper JL (2012) Inference about causation from examination of familial confounding: application to longitudinal twin data on mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 21(7):1149–1155. doi: 10.1158/1055-9965.EPI-12-0051 PubMedGoogle Scholar
  164. 164.
    Varghese JS, Thompson DJ, Michailidou K, Lindstrom S, Turnbull C, Brown J, Leyland J, Warren RM, Luben RN, Loos RJ, Wareham NJ, Rommens J, Paterson AD, Martin LJ, Vachon CM, Scott CG, Atkinson EJ, Couch FJ, Apicella C, Southey MC, Stone J, Li J, Eriksson L, Czene K, Boyd NF, Hall P, Hopper JL, Tamimi RM, Rahman N, Easton DF (2012) Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res 72(6):1478–1484. doi: 10.1158/0008-5472.CAN-11-3295 PubMedCentralPubMedGoogle Scholar
  165. 165.
    Greenwood CM, Paterson AD, Linton L, Andrulis IL, Apicella C, Dimitromanolakis A, Kriukov V, Martin LJ, Salleh A, Samiltchuk E, Parekh RV, Southey MC, John EM, Hopper JL, Boyd NF, Rommens JM (2011) A genome-wide linkage study of mammographic density, a risk factor for breast cancer. Breast Cancer Res 13(6):R132. doi: 10.1186/bcr3078 PubMedCentralPubMedGoogle Scholar
  166. 166.
    Maskarinec G, Morimoto Y, Daida Y, Shepherd J, Novotny R (2011) A comparison of breast density measures between mothers and adolescent daughters. BMC Cancer 11:330. doi: 10.1186/1471-2407-11-330 PubMedCentralPubMedGoogle Scholar
  167. 167.
    Giacomazzi J, Aguiar E, Palmero EI, Schmidt AV, Skonieski G, Duarte Filho D, Bock H, Saraiva-Pereira ML, Schuler-Faccini L, Camey SA, Caleffi M, Giugliani R, Ashton-Prolla P (2011) Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density. Braz J Med Biol Res 44(4):291–296Google Scholar
  168. 168.
    Sung J, Song YM, Stone J, Lee K, Jeong JI, Kim SS (2010) Genetic influences on mammographic density in Korean twin and family: the Healthy Twin study. Breast Cancer Res Treat 124(2):467–474. doi: 10.1007/s10549-010-0852-9 PubMedGoogle Scholar
  169. 169.
    Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, Karadag N, Cairo M, Wei C, Meric-Bernstam F, Brown P, Arun B, Hortobagyi GN, Sahin A, Chang JC (2010) Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density. Breast Cancer Res Treat 119(2):305–314. doi: 10.1007/s10549-009-0350-0 PubMedGoogle Scholar
  170. 170.
    de Moura Ramos EH, Martinelli S, Silva I, Nazario A, Facina G, Costa A, Carvalho C, Souza N (2009) Association between estrogen receptor gene polymorphisms and breast density in postmenopausal women. Climacteric 12(6):490–501. doi: 10.3109/13697130902952585 PubMedGoogle Scholar
  171. 171.
    Crandall CJ, Sehl ME, Crawford SL, Gold EB, Habel LA, Butler LM, Sowers MR, Greendale GA, Sinsheimer JS (2009) Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res 11(4):R51. doi: 10.1186/bcr2340 PubMedCentralPubMedGoogle Scholar
  172. 172.
    Kataoka M, Antoniou A, Warren R, Leyland J, Brown J, Audley T, Easton D (2009) Genetic models for the familial aggregation of mammographic breast density. Cancer Epidemiol Biomarkers Prev 18(4):1277–1284. doi: 10.1158/1055-9965.EPI-08-0568 PubMedGoogle Scholar
  173. 173.
    Chambo D, Kemp C, Costa AM, Souza NC, Guerreiro da Silva ID (2009) Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density. Braz J Med Biol Res 42(4):323–329Google Scholar
  174. 174.
    Woolcott CG, Maskarinec G, Haiman CA, Verheus M, Pagano IS, Le Marchand L, Henderson BE, Kolonel LN (2009) Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort. Breast Cancer Res 11(1):R10. doi: 10.1186/bcr2229 PubMedCentralPubMedGoogle Scholar
  175. 175.
    Douglas JA, Roy-Gagnon MH, Zhou C, Mitchell BD, Shuldiner AR, Chan HP, Helvie MA (2008) Mammographic breast density–evidence for genetic correlations with established breast cancer risk factors. Cancer Epidemiol Biomarkers Prev 17(12):3509–3516. doi: 10.1158/1055-9965.EPI-08-0480 PubMedCentralPubMedGoogle Scholar
  176. 176.
    Tamimi RM, Cox D, Kraft P, Colditz GA, Hankinson SE, Hunter DJ (2008) Breast cancer susceptibility loci and mammographic density. Breast Cancer Res 10(4):R66. doi: 10.1186/bcr2127 PubMedCentralPubMedGoogle Scholar
  177. 177.
    Diorio C, Brisson J, Berube S, Pollak M (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 17(4):880–888. doi: 10.1158/1055-9965.EPI-07-2500 PubMedGoogle Scholar
  178. 178.
    Verheus M, McKay JD, Kaaks R, Canzian F, Biessy C, Johansson M, Grobbee DE, Peeters PH, van Gils CH (2008) Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat 112(1):109–122. doi: 10.1007/s10549-007-9827-x PubMedGoogle Scholar
  179. 179.
    Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS (2007) Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 67(17):8412–8418. doi: 10.1158/0008-5472.CAN-07-1076 PubMedGoogle Scholar
  180. 180.
    Stone J, Gurrin LC, Byrnes GB, Schroen CJ, Treloar SA, Padilla EJ, Dite GS, Southey MC, Hayes VM, Hopper JL (2007) Mammographic density and candidate gene variants: a twins and sisters study. Cancer Epidemiol Biomarkers Prev 16(7):1479–1484. doi: 10.1158/1055-9965.EPI-07-0107 PubMedGoogle Scholar
  181. 181.
    Olson JE, Ma CX, Pelleymounter LL, Schaid DJ, Pankratz VS, Vierkant RA, Fredericksen ZS, Ingle JN, Wu Y, Couch F, Sellers TA, Weinshilboum RM, Vachon CM (2007) A comprehensive examination of CYP19 variation and breast density. Cancer Epidemiol Biomarkers Prev 16(3):623–625. doi: 10.1158/1055-9965.EPI-06-0781 PubMedGoogle Scholar
  182. 182.
    Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9(1):R18. doi: 10.1186/bcr1655 PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • C. W. Huo
    • 1
    Email author
  • G. L. Chew
    • 1
  • K. L. Britt
    • 2
  • W. V. Ingman
    • 3
  • M. A. Henderson
    • 1
    • 2
  • J. L. Hopper
    • 4
    • 5
  • E. W. Thompson
    • 1
    • 6
  1. 1.Department of SurgeryUniversity of MelbourneMelbourneAustralia
  2. 2.Peter MacCallum Cancer CentreMelbourneAustralia
  3. 3.School of MedicineUniversity of AdelaideAdelaideAustralia
  4. 4.Centre for M.E.G.A.The University of MelbourneMelbourneAustralia
  5. 5.School of Public HealthSeoul National UniversitySeoulKorea
  6. 6.St Vincent’s InstituteFitzroyAustralia

Personalised recommendations